Sampayan, Wenielyn B.
HRN: 23-22-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
CEFUROXIME 500MG (TAB)
07/10/2023
07/17/2023
PO
500mg
BID
RMLE+repair, Thinly MSAF
Waiting Final Action
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes